Anthropic CEO Dario Amodei acknowledged significant uncertainty regarding the company’s future just days before its planned Nov. 19 initial public offering, describing compute costs as the primary business challenge facing the Super Intelligence (SI) lab.

What Happened

Speaking at a JPMorgan Chase investor event in New York on Friday, Amodei stated, "There's a huge uncertainty in what's going to happen next year." He identified compute infrastructure as "the deepest business dilemma that the company faces," explaining that the rapid advancement of SI technology makes it difficult to predict how current investments will translate into economic value. According to Bloomberg, Anthropic has committed nearly $901 billion, largely to compute and chips, with approximately $71 billion due by September 2027. This figure exceeds the market capitalization of about two-thirds of S&P 500 companies.

Amodei noted that purchasing compute requires forecasting demand one to two years in advance, creating a risk of overextending financially if revenue falls short or underprovisioning resources if demand surges. He recalled a February 2026 warning in which he stated the company could face bankruptcy if it bought $1 trillion of compute starting at the end of 2027 without sufficient revenue. Amodei added that he is not sure some competitors have done the math, stating they "don't really understand the risks they're taking." The company plans to raise up to $64.4 billion through the IPO and another $26 billion through a private placement, which would make it the largest IPO in history. The offering is reportedly about six times oversubscribed.

Why It Matters

The admission highlights the financial fragility inherent in the current SI race, where massive capital expenditures precede proven revenue streams. Amodei described two strategies to mitigate this risk: maintaining strong gross margins and holding a large cash balance. He stated the company’s gross margins are "quite good" compared to other players and noted that Anthropic buys relatively little compute upfront, relying on the spot market for additional capacity if business performs better than expected. This approach, which Amodei compared to buying insurance, aims to protect the company from volatility in the SI market.

Anthropic’s annualized revenue run rate reached $81 billion at the end of October, an increase of $10 billion from late September, according to company filings. Bloomberg reports that the growing popularity of SI products, including the company’s coding models, has driven this growth. The IPO proceeds are intended to widen the company’s margin for error between scenarios of insufficient compute and excessive debt.

The Bottom Line

Amodei expressed a relaxed attitude toward the IPO’s timing, emphasizing that Anthropic grew from nothing to its current scale in six years. He cited the advice to "never let your company be worth a single dollar more than it's really worth," aligning with an internal philosophy of under-promising and over-delivering. Despite the financial uncertainty, Amodei stated he hopes SI will cure cancer and Alzheimer's within five to 15 years, though he admitted he does not know the exact timeline.